Stokes Family Office, LLC Abb Vie Inc. Transaction History
Stokes Family Office, LLC
- $898 Million
- Q4 2024
A detailed history of Stokes Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stokes Family Office, LLC holds 27,092 shares of ABBV stock, worth $5.16 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
27,092
Previous 24,035
12.72%
Holding current value
$5.16 Million
Previous $4.75 Million
1.43%
% of portfolio
0.54%
Previous 0.54%
Shares
21 transactions
Others Institutions Holding ABBV
# of Institutions
3,958Shares Held
1.26BCall Options Held
16.9MPut Options Held
13M-
Vanguard Group Inc Valley Forge, PA172MShares$32.7 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.96 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.37 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $337B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...